Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Elyasa Mustafa Elfaki, Hamad H. Alanazi, Bandar Alharbi, Salem Hussain Alharethi, Khalid Anwer, Taj Mohammad & Md. Imtaiyaz Hassan. (2023) Identification of novel c-Kit inhibitors from natural sources using virtual screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Read now
Koh Miura, Masayuki Satoh, Makoto Kinouchi, Kuniharu Yamamoto, Yasuhiro Hasegawa, Alex Philchenkov, Yoichiro Kakugawa & Tsuneaki Fujiya. (2014) The preclinical development of regorafenib for the treatment of colorectal cancer. Expert Opinion on Drug Discovery 9:9, pages 1087-1101.
Read now
Read now
Articles from other publishers (26)
Debmalya Das Gupta, Saurov Mahanta, Tanzim Nishad Ullah, Sanjib Kumar Das, Anjini Bellai, Hui Tag & Pallabi Kalita Hui. (2023) Identification of phytocompounds from Paris polyphylla Smith as potential inhibitors for HER2 & VEGFR2 cancer genes using molecular docking and molecular dynamics simulation studies. Vegetos.
Crossref
Crossref
Jan Petr. (2023) Determination of Tyrosine Kinase Inhibitors via Capillary Electrophoresis with Tandem Mass Spectrometry and Online Stacking Preconcentration. Pharmaceuticals 16:2, pages 186.
Crossref
Crossref
Chenglong Chen, Qianyu Shi, Jiuhui Xu, Tingting Ren, Yi Huang & Wei Guo. (2022) Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma. Cell Death Discovery 8:1.
Crossref
Crossref
João Figueira Scarini, Luccas Lavareze, Reydson Alcides de Lima-Souza, Carolina Emerick, Mayara Trevizol Gonçalves, Tayná Figueiredo-Maciel, Gustavo de Souza Vieira, Talita de Carvalho Kimura, Raisa Sales de Sá, Iara Gonçalves Aquino, Patricia Maria Fernandes, Luiz Paulo Kowalski, Albina Altemani, Fernanda Viviane Mariano & Erika Said Abu Egal. (2022) Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy. Critical Reviews in Oncology/Hematology 180, pages 103863.
Crossref
Crossref
Pooja Gupta, Tavneet Kaur Makkar, Lavisha Goel & Monika Pahuja. (2022) Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity. Immunologic Research 70:6, pages 725-741.
Crossref
Crossref
Sayed Reshad Ghafouri, Suvarna Guvvala, Catherine Jones & Alexander Philipovskiy. (2023) Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer. Journal of Investigative Medicine 70:6, pages 1329-1341.
Crossref
Crossref
Dipayan Paul, Saurov Mahanta, Hui Tag, Sanjib Kumar Das, Debmalya Das Gupta, Bhaben Tanti, Rajendran Ananthan, Ranjan Das, Sanjay Jambhulkar & Pallabi Kalita Hui. (2021) Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK—HER2 and VEGFR2 receptors, by in silico approach. Molecular Diversity 26:4, pages 1933-1955.
Crossref
Crossref
Ashish Shah, Chhagan Patel, Ghanshaym Parmar, Ashish Patel & Manav Jain. (2022) A Concise Review on Tyrosine Kinase Targeted Cancer Therapy. Current Drug Therapy 17:2, pages 96-107.
Crossref
Crossref
Seungbeom Lee, Jisu Kim, Jeyun Jo, Jae Won Chang, Jaehoon Sim & Hwayoung Yun. (2021) Recent advances in development of hetero-bivalent kinase inhibitors. European Journal of Medicinal Chemistry 216, pages 113318.
Crossref
Crossref
Liling Huang, Shiyu Jiang & Yuankai Shi. (2020) Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020). Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Min-Hee Kim, Tae Hyeong Lee, Jin Soo Lee, Dong-Jun Lim & Peter Chang-Whan Lee. (2020) Hif-1α Inhibitors Could Successfully Inhibit the Progression of Differentiated Thyroid Cancer in Vitro. Pharmaceuticals 13:9, pages 208.
Crossref
Crossref
Cheorl-Ho KimCheorl-Ho Kim. 2020. Ganglioside Biochemistry. Ganglioside Biochemistry
123
167
.
Simona Turco, Ahmed El Kaffas, Jianhua Zhou, Amelie M. Lutz, Hessel Wijkstra, Jürgen K. Willmann & Massimo Mischi. (2018) Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer. Molecular Imaging and Biology 21:4, pages 633-643.
Crossref
Crossref
Pengyu Chen, Hua Yue, Xiaobo Zhai, Zihan HuangGuang-Hui MaWei Wei & Li-Tang Yan. (2019) Transport of a graphene nanosheet sandwiched inside cell membranes. Science Advances 5:6.
Crossref
Crossref
Imane Naboulsi, Aziz Aboulmouhajir, Lamfeddal Kouisni, Faouzi Bekkaoui & Abdelaziz Yasri. (2018) Combining a QSAR Approach and Structural Analysis to Derive an SAR Map of Lyn Kinase Inhibition. Molecules 23:12, pages 3271.
Crossref
Crossref
Ning Li, Binrong Yao, Chunhua Wang, Qingguo Meng & Guige Hou. (2017)
Synthesis, crystal structure and activity evaluation of novel 3,4-dihydro-1-benzoxepin-5(2
H
)-one derivatives as protein–tyrosine kinase (PTK) inhibitors
. Acta Crystallographica Section C Structural Chemistry 73:11, pages 1003-1009.
Crossref
Crossref
Simona Turco, Isabelle Tardy, Peter Frinking, Hessel Wijkstra & Massimo Mischi. (2017) On the validity of the first-pass binding model for quantitative ultrasound molecular imaging: Comparison between BR55 and Sonovue. On the validity of the first-pass binding model for quantitative ultrasound molecular imaging: Comparison between BR55 and Sonovue.
Bing Liu, XinPing Huang, YunLong Hu, TingTing Chen, BoYa Peng, NingNing Gao, ZhenChao Jin, TieLiu Jia, Na Zhang, ZhuLin Wang & GuangYi Jin. (2016) Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer. Oncotarget 7:36, pages 58038-58050.
Crossref
Crossref
Simona Turco, Ahmed El Kaffas, Jianhua Zhou, Hessel Wijkstra, Juergen K Willmann & Massimo Mischi. (2016) Quantitative ultrasound molecular imaging for antiangiogenic therapy monitoring. Quantitative ultrasound molecular imaging for antiangiogenic therapy monitoring.
Jin Zhang, Xiangdong Jiang, Yingnan Jiang, Mingrui Guo, Shouyue Zhang, Jingjing Li, Jun He, Jie Liu, Jinhui Wang & Liang Ouyang. (2016) Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs. European Journal of Medicinal Chemistry 108, pages 495-504.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
495
547
.
Takahiro Amemiya, Masashi Honma, Yoshiaki Kariya, Samik Ghosh, Hiroaki Kitano, Yoshihisa Kurachi, Ken-ichi Fujita, Yasutsuna Sasaki, Yukio Homma, Darrel R Abernethy, Haruki Kume & Hiroshi Suzuki. (2015) Elucidation of the molecular mechanisms underlying adverse reactions associated with a kinase inhibitor using systems toxicology. npj Systems Biology and Applications 1:1.
Crossref
Crossref
Chaochao Xu, Wulan Li, Peihong Qiu, Yiqun Xia, Xiaojing Du, Fen Wang, Lailai Shen, Qiuxiang Chen, Yunjie Zhao, Rong Jin, Jianzhang Wu, Guang Liang & Xiaokun Li. (2015) The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer. Anti-Cancer Drugs 26:4, pages 379-387.
Crossref
Crossref
Maria J. Pineda de las Infantas, Sara Torres-Rusillo, Juan Diego Unciti-Broceta, Pablo Fernandez-Rubio, Maria Angelica Luque-GonzalezMiguel A. Gallo, Asier Unciti-Broceta, Ignacio J. Molina & Juan J. Diaz-Mochon. (2015) Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors. Organic & Biomolecular Chemistry 13:18, pages 5224-5234.
Crossref
Crossref
Jean-Yves Mérour, Frédéric Buron, Karen Plé, Pascal Bonnet & Sylvain Routier. (2014) The Azaindole Framework in the Design of Kinase Inhibitors. Molecules 19:12, pages 19935-19979.
Crossref
Crossref
Chun Li. (2014) A targeted approach to cancer imaging and therapy. Nature Materials 13:2, pages 110-115.
Crossref
Crossref